Supporting World Psoriasis Day
Janssen proudly joins the International Federation of Psoriasis Associations (IFPA) and the global psoriasis community to recognize World Psoriasis Day.
Psoriasis is a chronic, immune-mediated disease that affects more than 125 million people globally, or nearly three percent of the world’s population. Not only do people have to live with the uncomfortable and painful red patches, known as plaques, all over their bodies in many instances, but they are also at an increased risk for a variety of serious conditions including cardiovascular disease, diabetes and depression. As leaders in this disease area, we understand the importance of coming together to address the needs of the global psoriasis community.
At Janssen, we strive to meet these needs through innovative medicines that address the underlying cause of disease with the ultimate goal of allowing patients to live happy, healthy lives. With access to state-of-the-art technologies, and a team of world-renowned industry and academic partners, Janssen has just the right formula to discover, develop and deliver treatments today and tomorrow for people living with psoriasis around the globe.
You can learn more about psoriasis and our approach – and share the information with others – in our latest infographic.